Molecular Crosstalk Between Chronic Inflammation and Cancer Development
DOI:
https://doi.org/10.62896/Keywords:
Chronic inflammation, cancer development, molecular crosstalk, tumor initiation, tumor progression, signaling pathways, NFκB, JAK-STAT, MAPK, cytokines, chemokines, growth factors, reactive oxygen species, DNA damage, genomic instability, immune evasion, tumor microenvironmentAbstract
Chronic inflammation is increasingly recognized as a critical driver of cancer development, contributing to tumor initiation, progression, and metastasis. The molecular crosstalk between chronic inflammation and cancer involves complex signaling networks that alter cellular behavior and the tumor microenvironment. Inflammatory mediators, such as cytokines, chemokines, and growth factors, activate signaling pathways like NF-κB, JAK-STAT, and MAPK, which promote cell proliferation, survival, angiogenesis, and immune evasion. Additionally, chronic inflammation leads to the accumulation of reactive oxygen and nitrogen species, which induce DNA damage, further driving genomic instability. This paper explores the molecular mechanisms underlying the inflammatory response in cancer, focusing on the bidirectional interaction between immune cells and cancer cells. By examining key signaling molecules, transcription factors, and immune modulators involved in this crosstalk, the paper highlights potential therapeutic targets aimed at disrupting the inflammatory pathways that fuel carcinogenesis. Understanding the intricate relationship between chronic inflammation and cancer is crucial for the development of novel preventive and therapeutic strategies to combat inflammation-driven cancers.
